JPRN-UMIN000011346已完成未知
Insulin combined with the DPP-4 inhibitor sitagliptin for diabetes: evaluation study - I-UNITE Study
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 Hypersensitivity to sitagliptin 2 Patients who had severe ketosis or diabetic coma within 6 months 3 Severe infection or trauma, perioperative 4 Patients whose participation is deemed inappropriate at the discretion of the attending physician
研究者
相似试验
已完成
不适用
In combination therapy with insulin and DPP-4 inhibitor sitagliptin Study of efficacy and safetyJPRN-UMIN000009908Diabetes Center,Tokyo Women's Medical University50
已完成
不适用
Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetesType 2 diabetesJPRN-UMIN000006470Jikei University School of Medicine Kashiwa Hospital20
已完成
不适用
Effect of DPP-4 inhibitor or Metformin on insulin therapy in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000008155Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine40
进行中（未招募）
不适用
ANTIDIABETIC EFFECTS OF ADDING A DPP-4 INHIBITOR (SITAGLIPTIN) TO PRE-EXISTING TREATMENT WITH AN INCRETIN MIMETIC (LIRAGLUTIDE) IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH METFORMITYPE 2 DIABETESMedDRA version: 16.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2013-001764-35-DEDiabeteszentrum Bad Lauterberg
进行中（未招募）
1 期
DPP4inhibitors in Type 1 DiabetesType 1 DiabetesEUCTR2012-002407-18-GBniversity of Dundee and NHS Tayside12